Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
Apellis Pharmaceuticals (Nasdaq: APLS) has announced its participation in two upcoming investor conferences in September 2024. The company will be featured in fireside chats at the Wells Fargo Annual Healthcare Conference on September 5 at 9:30 a.m. ET and the Baird 2024 Global Healthcare Conference on September 11 at 9:05 a.m. ET.
Investors and interested parties can access live webcasts of these presentations through the 'Events and Presentations' page in the 'Investors and Media' section of Apellis' website. Replays of the webcasts will be available for approximately 90 days after the events, providing an opportunity for those unable to attend live to catch up on the company's latest updates and insights.
Apellis Pharmaceuticals (Nasdaq: APLS) ha annunciato la sua partecipazione a due prossimi conferenze per investitori nel settembre 2024. L'azienda sarà presente in conversazioni informali al Wells Fargo Annual Healthcare Conference il 5 settembre alle 9:30 ET e al Baird 2024 Global Healthcare Conference l'11 settembre alle 9:05 ET.
Gli investitori e le parti interessate possono accedere alle dirette web di queste presentazioni attraverso la pagina 'Eventi e Presentazioni' nella sezione 'Investitori e Media' del sito web di Apellis. Le registrazioni delle web dirette saranno disponibili per circa 90 giorni dopo gli eventi, offrendo un'opportunità a coloro che non possono partecipare dal vivo di aggiornarsi sugli ultimi sviluppi e intuizioni dell'azienda.
Apellis Pharmaceuticals (Nasdaq: APLS) ha anunciado su participación en dos próximas conferencias para inversores en septiembre de 2024. La compañía estará presente en charlas informales en la Wells Fargo Annual Healthcare Conference el 5 de septiembre a las 9:30 a.m. ET y en la Baird 2024 Global Healthcare Conference el 11 de septiembre a las 9:05 a.m. ET.
Los inversores y las partes interesadas pueden acceder a las transmisiones en vivo de estas presentaciones a través de la página 'Eventos y Presentaciones' en la sección 'Inversores y Medios' del sitio web de Apellis. Las repeticiones de las transmisiones estarán disponibles durante aproximadamente 90 días después de los eventos, ofreciendo a aquellos que no puedan asistir en vivo la oportunidad de ponerse al día con las últimas actualizaciones e información de la empresa.
Apellis Pharmaceuticals (Nasdaq: APLS)는 2024년 9월에 예정된 두 개의 투자자 회의에 참여할 것을 발표했습니다. 이 회사는 9월 5일 오전 9시 30분 ET에 웰스파고 연례 의료 회의와 9월 11일 오전 9시 5분 ET에 베어드 2024 글로벌 의료 회의에서 대화에 참여할 예정입니다.
투자자 및 관심 있는 당사자는 Apellis 웹사이트의 '투자자 및 미디어' 섹션에 있는 '이벤트 및 발표' 페이지를 통해 이러한 프레젠테이션의 실시간 웹캐스트에 접근할 수 있습니다. 웹캐스트의 재생은 이벤트 후 약 90일 동안 제공되어, 생방송에 참석할 수 없는 이들이 회사의 최신 업데이트 및 통찰력을 따라잡을 수 있는 기회를 제공합니다.
Apellis Pharmaceuticals (Nasdaq: APLS) a annoncé sa participation à deux conférences investisseurs à venir en septembre 2024. L'entreprise sera présente lors de discussions informelles à la Wells Fargo Annual Healthcare Conference le 5 septembre à 9h30 ET et à la Baird 2024 Global Healthcare Conference le 11 septembre à 9h05 ET.
Les investisseurs et les parties intéressées peuvent accéder aux webcasts en direct de ces présentations via la page 'Événements et Présentations' dans la section 'Investisseurs et Médias' du site Web d'Apellis. Les rediffusions des webcasts seront disponibles pendant environ 90 jours après les événements, offrant ainsi aux personnes qui ne peuvent pas assister en direct l'occasion de se tenir au courant des dernières mises à jour et analyses de l'entreprise.
Apellis Pharmaceuticals (Nasdaq: APLS) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2024 angekündigt. Das Unternehmen wird am 5. September um 9:30 Uhr ET in informellen Gesprächen auf der Wells Fargo Annual Healthcare Conference und am 11. September um 9:05 Uhr ET auf der Baird 2024 Global Healthcare Conference vertreten sein.
Investoren und Interessierte können die Live-Webcasts dieser Präsentationen über die Seite 'Veranstaltungen und Präsentationen' im Bereich 'Investoren und Medien' der Website von Apellis abrufen. Wiederholungen der Webcasts werden etwa 90 Tage nach den Veranstaltungen verfügbar sein und bieten somit die Möglichkeit, sich über die neuesten Updates und Einblicke des Unternehmens zu informieren, falls man nicht live teilnehmen kann.
- None.
- None.
WALTHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq: APLS) today announced that the company will participate in the following September investor conferences:
- Wells Fargo Annual Healthcare Conference 2024: Fireside chat on Thursday, September 5, 2024, at 9:30 a.m. ET
- Baird 2024 Global Healthcare Conference: Fireside chat on Wednesday, September 11, 2024, at 9:05 a.m. ET
The live conference webcasts will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcasts will be available for approximately 90 days following the event.
About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across serious retinal, rare, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.
Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178
FAQ
When is Apellis Pharmaceuticals (APLS) presenting at the Wells Fargo Annual Healthcare Conference in 2024?
What time is Apellis Pharmaceuticals (APLS) scheduled for the Baird 2024 Global Healthcare Conference?
How long will the webcasts of Apellis Pharmaceuticals' (APLS) investor conference presentations be available?
Where can I find the live webcasts of Apellis Pharmaceuticals' (APLS) September 2024 investor conference presentations?
